We’re expanding our Strategic Advisory Board with two former FDA leaders, Tala Fakhouri and Sean Khozin. Their guidance ensures Weave stays grounded in how regulators actually assess a submission, not in assumptions about it.
Press release
Two Former FDA Leaders Join Weave Bio’s Strategic Advisory Board
Related news
Press release
Weave Bio Enables Global Submissions
News
The Regulatory Expert Is Not Obsolete: Redefining Human Expertise in an AI-Accelerated Submission Environment
Press release
Weave Bio Launches NDA Workflow Designed in Partnership with Parexel; Extending AI-Native Platform Coverage Across the Full Regulatory Lifecycle
Press release